These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 10914738
1. Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells. Eguchi H, Nagano H, Yamamoto H, Miyamoto A, Kondo M, Dono K, Nakamori S, Umeshita K, Sakon M, Monden M. Clin Cancer Res; 2000 Jul; 6(7):2881-90. PubMed ID: 10914738 [Abstract] [Full Text] [Related]
2. Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases. Murphy D, Detjen KM, Welzel M, Wiedenmann B, Rosewicz S. Hepatology; 2001 Feb; 33(2):346-56. PubMed ID: 11172336 [Abstract] [Full Text] [Related]
6. Modulation of cdk2, cyclin D1, p16INK4a, p21WAF and p27Kip1 expression in endothelial cells by TNF/IFN gamma. Dormond O, Lejeune FJ, Ruegg C. Anticancer Res; 2002 Feb; 22(6A):3159-63. PubMed ID: 12530059 [Abstract] [Full Text] [Related]
7. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912 [Abstract] [Full Text] [Related]
8. Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line. Kuniyasu H, Yasui W, Kitahara K, Naka K, Yokozaki H, Akama Y, Hamamoto T, Tahara H, Tahara E. Cell Growth Differ; 1997 Jan 15; 8(1):47-52. PubMed ID: 8993833 [Abstract] [Full Text] [Related]
9. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Park WH, Seol JG, Kim ES, Jung CW, Lee CC, Binderup L, Koeffler HP, Kim BK, Lee YY. Exp Cell Res; 2000 Feb 01; 254(2):279-86. PubMed ID: 10640426 [Abstract] [Full Text] [Related]
10. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40. Han H, Nomura T, Honjo T, Tsubata T. Eur J Immunol; 1996 Oct 01; 26(10):2425-32. PubMed ID: 8898956 [Abstract] [Full Text] [Related]
11. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga H, Harada M, Ohtsubo M, Shishido S, Kumemura H, Hanada S, Taniguchi E, Yamashita K, Kumashiro R, Ueno T, Sata M. Hepatology; 2003 May 01; 37(5):1086-96. PubMed ID: 12717389 [Abstract] [Full Text] [Related]
12. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA, DeLorenzo RJ, Tombes RM. Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994 [Abstract] [Full Text] [Related]
15. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J. Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512 [Abstract] [Full Text] [Related]
16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 03; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
18. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049 [Abstract] [Full Text] [Related]